Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
NCT05171127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2023-03-09
Summary
Differentiation between glioma tumor tissue and normal cerebral tissue using Diffuse Reflectance Spectroscopy (DRS) on surgical tissue samples ex-vivo
Conditions
- Glioblastoma
- Surgical Margin
Interventions
- PROCEDURE
-
Diffuse Reflectance Spectroscopy
Measurements of DRS patterns in extirpated tumor and cerebral tissue
Sponsors & Collaborators
-
Philips Healthcare
collaborator INDUSTRY -
Karolinska University Hospital
lead OTHER
Principal Investigators
-
Oscar Persson, MD, PhD · Karolinska University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-30
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
NCT04822688 ·Status: COMPLETED
-
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572 ·Status: COMPLETED ·Phase: NA
-
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
NCT00967200 ·Status: COMPLETED
-
Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry
NCT00592709 ·Status: COMPLETED
-
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005083 ·Status: WITHDRAWN ·Phase: PHASE2
-
Establishment of a Brain and Spinal Tumor Tissue Bank
NCT00686387 ·Status: UNKNOWN
-
Developing Criteria for Cortical Resections
NCT00152659 ·Status: COMPLETED
-
Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy
NCT01212237 ·Status: WITHDRAWN
-
Evaluation of 3D Ultrasound in Brain Tumor Surgery
NCT05956977 ·Status: UNKNOWN ·Phase: NA
-
Enhanced Detection in Glioma Excision
NCT04556929 ·Status: TERMINATED ·Phase: NA
-
Mapping Molecular Markers of Brain Tumour Activity Using MRI
NCT05140785 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
NCT01106794 ·Status: RECRUITING
-
Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
NCT01798771 ·Status: UNKNOWN ·Phase: NA
-
Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
NCT02473484 ·Status: COMPLETED
-
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
NCT05793021 ·Status: RECRUITING ·Phase: NA
-
Genetic and Molecular Characterization of Nervous System Lesions
NCT06314607 ·Status: RECRUITING
-
Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
NCT01872221 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
NCT05100173 ·Status: COMPLETED
-
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor
NCT00001148 ·Status: COMPLETED
-
Pilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection of Gliomas
NCT04937244 ·Status: UNKNOWN ·Phase: PHASE4
-
Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue
NCT04545177 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multimodal Imaging of Hypoxia in Gliomas
NCT03716986 ·Status: UNKNOWN ·Phase: NA
-
Cryoablation of Brain Neoplasm
NCT06753617 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219 ·Status: COMPLETED
-
A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes
NCT01251913 ·Status: TERMINATED